$PG · The Procter & Gamble Company

The Procter & Gamble Company filed a Form 4 with the SEC on November 5, 2026, reporting transactions by Chief Financial Officer Andre Schulten. According to the filing, on November 4, 2026, Schulten exercised stock options to acquire 33,624 shares of common stock at an exercise price of $91.07 per share. On the same day, he sold all 33,624 of those shares at $165.00 per share.

The exercised options were originally granted with an exercisable date of February 28, 2020, and an expiration date of February 26, 2027. Following the reported transactions, Schulten directly owned 65,618.0097 shares of common stock, with an additional 7,604.419 shares held indirectly through a retirement plan trustee. The option exercise and sale resulted in no remaining derivative securities of that class being beneficially owned by him.

The filing is a routine disclosure of insider transactions under Section 16(a) of the Securities Exchange Act of 1934 and does not contain any additional explanation beyond the reported trades and resulting holdings.